Delivery Order SPE2DB24D1007-SPE2DB24FBZEG
Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,376.31, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 13, 2024 with a completion date of June 14, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025....
- The federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,923.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. This award is associated with Amerisourcebergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of XELJANZ 10 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $45,705.77 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. It is not designated as a set-aside contract. This delivery order...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S to the Defense Logistics Agency (DLA), a defense agency. The $7,029.36 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025 with a completion date of July 18, 2025. The contract is not a set-aside and is likely part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET UU 60S, a prescription medication, to the Defense Logistics Agency (DLA). The contract, valued at $2,967.45, was awarded to the corporate office of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- The federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $15,504.59, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 4, 2025 with an ultimate completion date of April 7, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $10,328.41 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025 with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of XELJANZ 5 MG TABLET (NDC 00069-0501-60) from Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $4,473.51, has a period of performance through May 24, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,312.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is December 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,282.65 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 20, 2024, with a completion date of August 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...